<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4566DCD4-FC2C-42C4-A55E-45935E9A5F09"><gtr:id>4566DCD4-FC2C-42C4-A55E-45935E9A5F09</gtr:id><gtr:name>Angkor Hospital for Children</gtr:name><gtr:address><gtr:line1>Tep Vong (Achamean) Road &amp; Oum Chhay St</gtr:line1><gtr:line2>Svay Dangkum</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9BD87D37-3C59-4ADA-B289-086FD765B2A9"><gtr:id>9BD87D37-3C59-4ADA-B289-086FD765B2A9</gtr:id><gtr:name>Queen Sirikit National Institute of Child Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75AEC807-087D-48FC-A11C-9FD0D3DCB516"><gtr:id>75AEC807-087D-48FC-A11C-9FD0D3DCB516</gtr:id><gtr:name>Albert Ludwigs University of Freiburg</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/850FC189-F1EA-472B-8E60-0F1DBA42212D"><gtr:id>850FC189-F1EA-472B-8E60-0F1DBA42212D</gtr:id><gtr:name>Wellcome Trust-Mahosot Hospital-Oxford University Tropical Medicine Research Collaboration</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Tropical Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4566DCD4-FC2C-42C4-A55E-45935E9A5F09"><gtr:id>4566DCD4-FC2C-42C4-A55E-45935E9A5F09</gtr:id><gtr:name>Angkor Hospital for Children</gtr:name><gtr:address><gtr:line1>Tep Vong (Achamean) Road &amp; Oum Chhay St</gtr:line1><gtr:line2>Svay Dangkum</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9BD87D37-3C59-4ADA-B289-086FD765B2A9"><gtr:id>9BD87D37-3C59-4ADA-B289-086FD765B2A9</gtr:id><gtr:name>Queen Sirikit National Institute of Child Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75AEC807-087D-48FC-A11C-9FD0D3DCB516"><gtr:id>75AEC807-087D-48FC-A11C-9FD0D3DCB516</gtr:id><gtr:name>Albert Ludwigs University of Freiburg</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/850FC189-F1EA-472B-8E60-0F1DBA42212D"><gtr:id>850FC189-F1EA-472B-8E60-0F1DBA42212D</gtr:id><gtr:name>Wellcome Trust-Mahosot Hospital-Oxford University Tropical Medicine Research Collaboration</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CD6BF751-E57C-4B7B-92F6-EB9404D6800A"><gtr:id>CD6BF751-E57C-4B7B-92F6-EB9404D6800A</gtr:id><gtr:firstName>Ben</gtr:firstName><gtr:otherNames>Symons</gtr:otherNames><gtr:surname>Cooper</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/03ACA04B-4000-4EFF-B629-9828AD147CB0"><gtr:id>03ACA04B-4000-4EFF-B629-9828AD147CB0</gtr:id><gtr:firstName>Yoel</gtr:firstName><gtr:surname>Lubell</gtr:surname><gtr:orcidId>0000-0002-0237-1070</gtr:orcidId><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7088722D-B8A6-4811-871C-2D3CCCC31B92"><gtr:id>7088722D-B8A6-4811-871C-2D3CCCC31B92</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>Philip</gtr:otherNames><gtr:surname>Day</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK006924%2F1"><gtr:id>1485D88C-D64F-414F-B689-AED387BEDB2F</gtr:id><gtr:title>Developing and evaluating a framework for the rational design of antibiotic prescribing policies in resource-constrained hospital settings</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MR/K006924/1</gtr:grantReference><gtr:abstractText>When hospitalised patients have a serious bacterial infection, they are usually given antibiotics. In rich countries, one third of the time the antibiotics are ineffective. This is often because the bacteria have acquired a gene that makes them resistant to that antibiotic. While it is possible to test for such resistance, it takes three or four days to get a result. For patients with serious infections this delay can be the difference between life and death.

In lower income countries the same is likely to be true, but little data are available. We do, however, know that patients in hospitals in poorer countries get infections more often and when they do they are more likely to die. Infections caused by antibiotic-resistant bacteria are also a major problem. As well as delaying effective treatment, such resistance can claim lives in low-income settings because remaining effective antibiotics are not available. Even if they are, they may be too expensive for many patients. The research aims to address the question of how we can more often give patients effective antibiotics when they need them and less often when they don't in hospitals with limited resources. We also want to find out how different antibiotics affect the spread of the most dangerous antibiotic-resistant bacteria, and we want to see if by changing patterns of antibiotic prescribing we can reduce the number of infections with resistant bacteria.

One part of the proposed work will use patient data (age, time in hospital, date last hospitalised, etc) and look for patterns that help to predict how likely infections with different types of bacteria are. For example, we know that patients who have been in hospital a long time are more likely to have infections with resistant bacteria. We can use this information to help choose which antibiotic is most likely to be effective. Our hunch is that by using computer models we can make optimal use of the information and choose an effective antibiotic more often than currently happens.

The second consideration doctors have to take into account when prescribing antibiotics is how this will affect other patients. The reason is that the more an antibiotic is used the more it creates an environment favourable to antibiotic-resistant bacteria. In general, increasing antibiotic use is associated with increased resistance to that antibiotic. The specifics, however, are complicated: some antibiotics promote resistance much more than others, and sometimes use of one antibiotic can cause an increase in resistance against a completely different antibiotic. To help design good antibiotic policies we need to understand these complex mechanisms better. Another part of the work will therefore use a computer modelling approach and new statistical techniques to develop and apply better methods to understand how levels of resistance change in response to changing antibiotic use. 

The next stage of the research will combine these computer models and make extensive use of expertise from infectious disease doctors to design the best antibiotic policy we can for two hospitals. We will evaluate new policies in two ways: first we will run computer simulations, using real data from the hospitals to predict how well the new policy performs. If it performs worse than current practice we will redesign the policy until it performs better. Then, in one of the hospitals, we will perform an intervention study where we introduce the new policy and evaluate whether it really does improve antibiotic prescribing and reduce resistance as predicted.

Finally, use of new rapid tests that help determine what type of bugs are causing an infection can mean a patient has more chance of getting effective antibiotic treatment when it is needed and less chance of unnecessary treatment. We will use the previously-developed computer models to estimate how much patients would benefit from such tests, and evaluate which would represent good value for money.</gtr:abstractText><gtr:technicalSummary>Empirical antibiotic therapy for hospitalized patients should be chosen based on consideration of the likely pathogens, local antibiotic susceptibility patterns, patient-specific factors relating to severity of illness and risk of infection with a resistant organism, cost-effectiveness, and the impact of the antibiotic on the selection for resistant bacteria within the patient and the hospital. 

Designing antibiotic polices to satisfy these complex and competing requirements is difficult. Wide variation in resistance patterns and different local incidence rates with different organisms prevent simple generalization of findings from clinical trials. Currently setting-specific choices of empirical therapy are made using clinical judgement alone, without the support of quantitative analysis or a coherent framework for balancing the competing requirements. We hypothesize that patient outcomes could be improved in a cost-effective (and potentially cost-saving) manner and antibiotic resistance reduced by implementing an evidence-based approach to the design of antibiotic policies. 

This proposal aims to develop and evaluate such a framework for the rational design of antibiotic policies and to quantify the value of improving prescribing through investment in enhanced diagnostic capability. This will involve developing, extending and synthesizing a suite of phenomenological and mechanistic modelling approaches for quantifying the impact of prescribing decisions on patient and population-level outcomes. We propose to evaluate this approach using both in silico experiments using real hospital data and in a cluster-randomized trial. 

While this proposal has global significance, we will focus exclusively on the choice of empirical therapy in low and middle income countries in Asia, where the potential health benefits are greatest and where the prevalence, local impact and international significance of antibiotic resistance make it a global health priority.</gtr:technicalSummary><gtr:potentialImpactText>Though the precise burden of disease is unclear, serious bacterial infections are one of the most important causes of morbidity and mortality in developing countries. Bacterial infections acquired in hospital are also a major cause of morbidity and mortality globally. While healthcare associated infections (HCAIs) affect 5-10% of acute-care patients in developed countries, infection rates are far higher in developing countries and the consequences more severe. The best estimate is that about 15 in every 100 acute care patients in developing countries acquire an infection. Serious infections are also common. At the proposed study site in Thailand, for example, at least one in every 200 in-patients staying for more than two days acquires a bacteraemia. Though reliable data are lacking and few high quality studies have been conducted, there are reasons for thinking that hospital infections could be amongst the leading causes of death in developing countries. Such infections also place a large burden on already stretched health services in resource-poor settings. Efforts to reduce neonatal mortality by referring high-risk births to healthcare settings may also be undermined if neonates have high probabilities of contracting HCAIs. For all these reasons, control of HCAIs is considered a major priority for developing countries by the World Health Organization.

Few studies from developing countries have reported data on antibiotic resistance, but it is clear that this represents a major problem, particularly in Southeast Asia. Previous research at our study sites in Thailand and Cambodia has shown a high prevalence of infection with methicillin-resistant Staphylococcus aureus. Gram-negative bacteria account for an even greater burden of disease in Southeast Asia and here resistance is an even bigger concern. At the study site in Thailand Gram-negative infections account for 78% of bacteraemias and 59% of these are multiply antibiotic resistant (resistant to three or more classes of antibiotics). The situation could get far worse. The emergence of NDM-1 plasmids conferring resistance to nearly all antibiotics and capable of transfer to most important Gram-negative bacteria is a profound global concern. The NDM-1 pandemic appears to have originated in healthcare institutions in New Delhi and spread has recently been documented to many other countries and continents. One of the best ways to slow the spread of such multiply resistant bacteria in (and between) hospitals is to reduce antibiotic selection pressure by reducing unnecessary use and changing the antibiotics used (other measures are also important, and at the site in Thailand we are evaluating a hospital-wide hand hygiene programme).

The research will address these problems in three ways. First, amongst patients with serious bacterial infections, it will aim to increase the proportion who receive adequate antibiotic therapy by developing simple algorithms to identify those at risk of harbouring resistant bacteria. Second, it will aim to develop algorithms to inform antibiotic policies that reduce unnecessary use of antibiotics and reduce resistance. Third, it will aim to identify cost-effective investments in improved diagnostic capability that developing countries can make to help target antibiotic use more effectively.

The research also has significance beyond Southeast Asia. In the short term this is because the region, which has a large population and high antibiotic use (in hospitals, the community, and in animal husbandry) is a major potential source for novel resistance determinants capable of rapid global dissemination. Ultimately, however, the aim is to have a much larger impact by taking the guesswork out of antibiotic prescribing and policy-making, and to develop tools and approaches that can be used to help design the robust, effective and evidence-based prescribing policies that are needed to mitigate the global problem of antibiotic resistance.</gtr:potentialImpactText><gtr:fund><gtr:end>2020-02-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2044180</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Sirikit National Institute of Child Health</gtr:collaboratingOrganisation><gtr:country>Thailand, Kingdom of</gtr:country><gtr:description>QSNICH</gtr:description><gtr:id>DF538EFB-2D51-46A6-8DA6-5D3D49F15E25</gtr:id><gtr:impact>Data has been collected and we an initial paper describing preliminary findings is being prepared. Brief details were reported at the SMBE Satellite Meeting in Japan 2016.</gtr:impact><gtr:outcomeId>54619b1d46a339.86912394-1</gtr:outcomeId><gtr:partnerContribution>Collaboration in the carriage study</gtr:partnerContribution><gtr:piContribution>Design of carriage study for multiply reistant organisms in neonatal intensive care unit</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Albert Ludwigs University of Freiburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Center for Medical Biometry and Medical Informatics</gtr:department><gtr:description>Freiburg collaboration</gtr:description><gtr:id>F2382424-6BCB-4A66-99D8-A854263711B0</gtr:id><gtr:impact>Wolkewitz M, Cooper BS, Bonten MJM, Barnett AG, Schumacher M (2014). Interpreting and comparing risks in the presence of competing events. BMJ 349:g5060 .</gtr:impact><gtr:outcomeId>58c8c8322e8e03.39088294-1</gtr:outcomeId><gtr:partnerContribution>Primary analysis, development and dissemination</gtr:partnerContribution><gtr:piContribution>Contributed to development and dissemination of ideas on statistical approaches to analysing time to event data in hospital infection data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust-Mahosot Hospital-Oxford University Tropical Medicine Research Collaboration</gtr:collaboratingOrganisation><gtr:country>Lao People's Democratic Republic</gtr:country><gtr:description>LOMWRU</gtr:description><gtr:id>7B5EB243-4CA1-4D95-A844-9465A0E18B4D</gtr:id><gtr:impact>No outputs yets</gtr:impact><gtr:outcomeId>56d7eed3aff0d4.91149295-1</gtr:outcomeId><gtr:partnerContribution>Partners will contribute data and clinical expertise.</gtr:partnerContribution><gtr:piContribution>Initiated collaboration to collected and analyse historical antimicrobial resistance (AMR) data and antibiotic useage data, with a view to better understanding epidemiology of AMR in those low income setting and the drivers for recent changes. My team will contribute analytical capacity.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Angkor Hospital for Children</gtr:collaboratingOrganisation><gtr:country>Cambodia, Kingdom of</gtr:country><gtr:description>AHC</gtr:description><gtr:id>20A9367E-ACAD-4FC9-8B7A-07A2289A0316</gtr:id><gtr:impact>The first publication describing results from this study has been accepted and is now in press at PIDJ:

Turner P, Pol S, Soeng S, Sar P, Neou L, Chea P, Day N, Cooper B, Turner C (2016). Extremely high prevalence of disease-associated an- timicrobial resistant Gram negative colonisation in hospitalized Cam- bodian young infants. Paed Infect Dis Journal. In press.</gtr:impact><gtr:outcomeId>koJsUceDnJK-1</gtr:outcomeId><gtr:partnerContribution>We are working with AHC to study the carriage of multiply resistant Gram-negative bacteria in infants in a newly formed neonatal intensive care unit.</gtr:partnerContribution><gtr:piContribution>Angkor Hospital for Children (AHC) in Siem Reap, Cambodia</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>Vietnam, Socialist Republic of</gtr:country><gtr:department>Oxford University Clinical Research Unit Vietnam (OUCRU)</gtr:department><gtr:description>OUCRU</gtr:description><gtr:id>DFD6873C-6788-4240-86EC-5BEF23658EE4</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:outcomeId>56d7ef7170c8d2.37385670-1</gtr:outcomeId><gtr:partnerContribution>Genomics expertise and also data from an epidemiological study.</gtr:partnerContribution><gtr:piContribution>Initiated a collaboration to pool expertise in modelling (contributed by my team) and genomics (contributed by OUCRU) to better understand epidemiology of Klebsiella pneumoniae in SE Asia.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cafe Scientifique, Bangkok</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D64F4659-6CE0-4B74-8A4F-0C1E02E2BF36</gtr:id><gtr:impact>Presentation at the Bangkok Science Cafe (Cafe Scientifique).
Intended purpose - to engage with general public interested in science.
This included a 30 minute talk and discussion with the audience afterwards. Quite wide-ranging including both AMR, evaluation of Ebola drugs, and, more generally, evidence based medicine. A number of participants tweeted about this event enabling it to reach a wider audience. Lots of positive feedback online afterwards too.</gtr:impact><gtr:outcomeId>56d7f218f25c48.59162713</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.meetup.com/bkksci/events/219636239/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog entry at  Reflections on Infection Control website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7957E1B9-AC8D-45A6-B0DE-71A3301FC00B</gtr:id><gtr:impact>Blog entry and popular website (REFLECTIONS ON INFECTION PREVENTION AND CONTROL ) highlighting recent research by collaborator</gtr:impact><gtr:outcomeId>58c8d22f880da0.22547634</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://reflectionsipc.com/2017/03/13/fluoroquinolone-use-and-c-difficile-infections-the-english-miracle-not-yet-explained/#more-2761</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Podcast about research for Oxford NDM website</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8324114A-9B85-4F9C-8B54-70EA06CC0C7B</gtr:id><gtr:impact>Recorded a &amp;quot;video podcast&amp;quot; for the oxford website, talking about research for a general audience. 
This is still being edited so hasn't been released yet, but it should be online very soon. 

Hence no impact yet</gtr:impact><gtr:outcomeId>56d7f2e2a87e30.62209037</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>299065</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>JPI-EC-AMR (Joint programming initiative on antimicrobial resistance)</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/R004536/1</gtr:fundingRef><gtr:id>238B8A27-DA9F-4BAE-A6A9-CF3777B6AB41</gtr:id><gtr:outcomeId>58c8cbce732066.19635723</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Systematic review and network meta-analysis of hand hygiene interventions in hospitals in BMJ (would be expected to feed into policy decisions, leading to increased take-up of intervention, but difficult to quantify effect for now and only published recently)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E79DC8E8-788D-430E-AB8B-57B4A90F7ACA</gtr:id><gtr:outcomeId>56d94c106e0db1.64108685</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Short course: introduction to epidemiological and economic modelling of infectious diseases</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>E5766D6A-9A23-4B55-9960-8E0274DAF2E2</gtr:id><gtr:impact>Taught skills in modelling studies and associated economic analysis ( both in critical understanding and implementation). Mixed audience but a significant proportion were made up of representatives from national health departments from the SE Asia region and this increased training of workforce would be expected to lead to indirect health impacts</gtr:impact><gtr:outcomeId>56d94ded6373a5.40210242</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Results form one year carriage study of multiply-resistant Gram negative bacteria in neonates admitted to AHC</gtr:description><gtr:id>35A4FFA9-BEF7-4B1D-9C0E-1144D0803782</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:outcomeId>54607fd082eb94.73008005</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Research database of carriage of multiply-resistant Gram negative bacteria admitted to a NICU in Cambodia</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Theoretical model for understanding epidemiological interactions between resistant and sensitive bacteria in hospitals and the community, and how hospital interventions impact on these. 

Note this is also listed under software.</gtr:description><gtr:id>EA95CF62-0C97-4054-B971-90A162ADFF80</gtr:id><gtr:impact>Not yet....we've only just posted it, but the underlying model is discussed here 

https://reflectionsipc.com/2017/03/13/fluoroquinolone-use-and-c-difficile-infections-the-english-miracle-not-yet-explained/#more-2761</gtr:impact><gtr:outcomeId>58c8d0d920c5a9.09606143</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Model of interactions resistant and sensitive bacteria in hospital and community</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:url>https://zenodo.org/record/345136#.WMjTes49--L</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Theoretical model for understanding epidemiological interactions between resistant and sensitive bacteria in hospitals and the community, and how hospital interventions impact on these.</gtr:description><gtr:id>204198AD-0A98-409C-9816-56D06CF8CB7B</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>58c8d2e06d1253.89208232</gtr:outcomeId><gtr:title>Model of interactions resistant and sensitive bacteria in hospital and community</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://zenodo.org/record/345136#.WMjTes49--L</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>531AEEBE-4F2F-4727-A714-809B3313B755</gtr:id><gtr:title>Reconstructing transmission trees for communicable diseases using densely sampled genetic data.</gtr:title><gtr:parentPublicationTitle>The annals of applied statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c618770c26ad930499fcb5c0265ae3dc"><gtr:id>c618770c26ad930499fcb5c0265ae3dc</gtr:id><gtr:otherNames>Worby CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6157</gtr:issn><gtr:outcomeId>56d7ecc399fbc8.19469174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20302943-931F-44E8-82FB-B6AE2905EB01</gtr:id><gtr:title>Modelling Transmission of Vancomycin-Resistant Enterococci in Intensive Care Units.</gtr:title><gtr:parentPublicationTitle>Statistical Methods in Medical Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74c7527dc2bbf15fadf582ed815befa6"><gtr:id>74c7527dc2bbf15fadf582ed815befa6</gtr:id><gtr:otherNames>Wei Y</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>56d7ec2612e191.18740274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD9CB18E-B2B3-41C8-8324-56D8E8AE1B09</gtr:id><gtr:title>Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20a981709f8dddafbd86c8150d896496"><gtr:id>20a981709f8dddafbd86c8150d896496</gtr:id><gtr:otherNames>Deeny SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>56d7e48567fe96.34562601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE399A54-BDCD-4D6D-A18E-BD78AD2E0B63</gtr:id><gtr:title>Variable performance of models for predicting methicillin-resistant Staphylococcus aureus carriage in European surgical wards.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e4b2251ec147bf99a843440509319ba"><gtr:id>7e4b2251ec147bf99a843440509319ba</gtr:id><gtr:otherNames>Lee AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>5675e28ad537a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>875CC067-66D4-4396-91E1-CCE41B1257BD</gtr:id><gtr:title>Multiple time scales in modeling the incidence of infections acquired in intensive care units.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f31a06d42a1bf74bb0acb92188c38d03"><gtr:id>f31a06d42a1bf74bb0acb92188c38d03</gtr:id><gtr:otherNames>Wolkewitz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>58c8c22418b6a6.73419586</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD586656-48E3-4E34-A692-B345D09A63F5</gtr:id><gtr:title>Reconstructing transmission trees for communicable diseases using densely sampled genetic data</gtr:title><gtr:parentPublicationTitle>The Annals of Applied Statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/114f2f5cd522c534d47157d0fcbb7f15"><gtr:id>114f2f5cd522c534d47157d0fcbb7f15</gtr:id><gtr:otherNames>Worby C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d6fcb38d262.74047190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5F22082-1306-4927-815E-5162AC757F01</gtr:id><gtr:title>Increasing incidence of hospital-acquired and healthcare-associated bacteremia in northeast Thailand: a multicenter surveillance study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/765e322be9d2c0b7b8862d00765a7493"><gtr:id>765e322be9d2c0b7b8862d00765a7493</gtr:id><gtr:otherNames>Hongsuwan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54607def3f0e09.91488252</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17A4EF12-DBBF-420D-88F4-AA48EA3B5B1E</gtr:id><gtr:title>Long-term survival after intensive care unit discharge in Thailand: a retrospective study.</gtr:title><gtr:parentPublicationTitle>Critical care (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0447278acee894192125f44a78ce85c6"><gtr:id>0447278acee894192125f44a78ce85c6</gtr:id><gtr:otherNames>Luangasanatip N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1364-8535</gtr:issn><gtr:outcomeId>pm_23741_21_24090280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10CEB7A2-E73E-494D-9B50-AA4DDBC4EB8A</gtr:id><gtr:title>Interpreting and comparing risks in the presence of competing events.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f31a06d42a1bf74bb0acb92188c38d03"><gtr:id>f31a06d42a1bf74bb0acb92188c38d03</gtr:id><gtr:otherNames>Wolkewitz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>54607def197990.60000550</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16D2CA10-8A01-4C84-ACB3-85EC8F53B788</gtr:id><gtr:title>High Prevalence of Antimicrobial-resistant Gram-negative Colonization in Hospitalized Cambodian Infants.</gtr:title><gtr:parentPublicationTitle>The Pediatric infectious disease journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3ffa5386909a665d59e0d3e31b6c2e1"><gtr:id>f3ffa5386909a665d59e0d3e31b6c2e1</gtr:id><gtr:otherNames>Turner P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0891-3668</gtr:issn><gtr:outcomeId>56d7eb81d8eba8.70710650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EB42829-237D-417C-AFD3-EFEB81ED3348</gtr:id><gtr:title>Why sensitive bacteria are resistant to hospital infection control.</gtr:title><gtr:parentPublicationTitle>Wellcome open research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d989d3e5cabfba8df227f5d81d126cc6"><gtr:id>d989d3e5cabfba8df227f5d81d126cc6</gtr:id><gtr:otherNames>van Kleef E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2398-502X</gtr:issn><gtr:outcomeId>5a35197010cb74.76611979</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D323FAE8-3B3C-4A55-964C-36BAB9D8C4AD</gtr:id><gtr:title>Impact of a structured ICU training programme in resource-limited settings in Asia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b421c04850a9d370ae1350a37cd74424"><gtr:id>b421c04850a9d370ae1350a37cd74424</gtr:id><gtr:otherNames>Haniffa R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa8de041c6e42.05351457</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79EF722D-7F1F-485B-A1A8-2277C711E523</gtr:id><gtr:title>Positive selection and compensatory adaptation interact to stabilize non-transmissible plasmids.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b3c81340684f22671f0914f64946f4a"><gtr:id>2b3c81340684f22671f0914f64946f4a</gtr:id><gtr:otherNames>San Millan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>54607deee489d7.15461357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24BC5B77-14C4-436D-8A3B-8A868D39E4CD</gtr:id><gtr:title>Multilevel competing risk models to evaluate the risk of nosocomial infection.</gtr:title><gtr:parentPublicationTitle>Critical care (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f31a06d42a1bf74bb0acb92188c38d03"><gtr:id>f31a06d42a1bf74bb0acb92188c38d03</gtr:id><gtr:otherNames>Wolkewitz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1364-8535</gtr:issn><gtr:outcomeId>pm_23741_21_24713511</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79EB416D-4DED-4A2C-8247-5D1D8797423C</gtr:id><gtr:title>A current perspective on antimicrobial resistance in Southeast Asia.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a262cf91e7efcb3bb79c1b1790e44cf"><gtr:id>8a262cf91e7efcb3bb79c1b1790e44cf</gtr:id><gtr:otherNames>Zellweger RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>5aa8dd3d001834.11148669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D4253E1-BCEA-4227-9C7E-C9EFEDE38478</gtr:id><gtr:title>Evaluating clinical trial designs for investigational treatments of Ebola virus disease.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/457e6907110388912b1d899289ee3a1c"><gtr:id>457e6907110388912b1d899289ee3a1c</gtr:id><gtr:otherNames>Cooper BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5675e26fdebcb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1072C44-CADE-4607-8A64-AEB777F5C1FC</gtr:id><gtr:title>Mortality attributable to seasonal influenza A and B infections in Thailand, 2005-2009: a longitudinal study.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/457e6907110388912b1d899289ee3a1c"><gtr:id>457e6907110388912b1d899289ee3a1c</gtr:id><gtr:otherNames>Cooper BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>5675e2f09b9bd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F46C95D-A23A-4872-A0F1-603D2ADFBF10</gtr:id><gtr:title>Seasonal influenza vaccination for children in Thailand: a cost-effectiveness analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69436220f5d9020d7ad9dc999bd8f44b"><gtr:id>69436220f5d9020d7ad9dc999bd8f44b</gtr:id><gtr:otherNames>Meeyai A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5675e5336fba5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24B334E9-E374-442D-865F-2E0AE90BBD76</gtr:id><gtr:title>More Research Is Needed to Quantify Risks, Benefits, and Cost-Effectiveness of Universal Mupirocin Usage.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20a981709f8dddafbd86c8150d896496"><gtr:id>20a981709f8dddafbd86c8150d896496</gtr:id><gtr:otherNames>Deeny SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56d7e4f947a1c6.42323301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F93C1002-BC33-48B7-BF5B-EE588100C529</gtr:id><gtr:title>Evidence for Community Transmission of Community-Associated but Not Health-Care-Associated Methicillin-Resistant Staphylococcus Aureus Strains Linked to Social and Material Deprivation: Spatial Analysis of Cross-sectional Data.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/acc6031bd793174196b137e434d58baf"><gtr:id>acc6031bd793174196b137e434d58baf</gtr:id><gtr:otherNames>Tosas Auguet O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>56d7e485bae020.85217537</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3158A04D-5015-4307-8D80-846077C1F72A</gtr:id><gtr:title>Simulations for designing and interpreting intervention trials in infectious diseases.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ea2b5c4040a8c3378e3a3f441da21e4"><gtr:id>0ea2b5c4040a8c3378e3a3f441da21e4</gtr:id><gtr:otherNames>Halloran ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>5a67889ac65938.38513024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A73DA19-327E-4205-8EBF-E75414FFD97C</gtr:id><gtr:title>Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a128bde71b61ac584877f6f0924cf6b8"><gtr:id>a128bde71b61ac584877f6f0924cf6b8</gtr:id><gtr:otherNames>Derde LPG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>pm_23741_21_24161233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1BE3239-A3BE-4C56-A388-76417B4CA215</gtr:id><gtr:title>Comparative efficacy of interventions to promote hand hygiene in hospital: systematic review and network meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0447278acee894192125f44a78ce85c6"><gtr:id>0447278acee894192125f44a78ce85c6</gtr:id><gtr:otherNames>Luangasanatip N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>585d6fc75b8015.83649039</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K006924/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>B7F5A9CA-62C7-4E68-A2B2-3D6CCA85E16B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>7.3  Management and decision making</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CCD4E5D4-D30B-4BCF-9FE1-D8BFC3DD43D3</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>8.3  Policy, ethics and research governance</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>